• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Myriad Genetics, Inc. (MYGN)

    -NasdaqGS
    34.21 Up 0.09(0.26%) Feb 12, 4:00PM EST
    |After Hours : 34.22 Up 0.01 (0.02%) Feb 12, 5:07PM EST
    Prev Close:34.12
    Open:34.51
    Bid:32.60 x 500
    Ask:N/A
    1y Target Est:42.00
    Beta:0.098561
    Earnings Date:May 3 - May 9 (Est.)
    Day's Range:33.87 - 34.94
    52wk Range:30.30 - 46.24
    Volume:1,385,900
    Avg Vol (3m):942,639
    Market Cap:2.44B
    P/E (ttm):25.72
    EPS (ttm):1.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MYGNUp 0.26%2.44B
    ABTUp 2.17%55.39B

    Key Statistics

    Forward P/E (1 yr):18.29
    P/S (ttm):3.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :1.66
    Quarterly EPS Est (Mar-16) :0.38
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback